204 related articles for article (PubMed ID: 31365477)
1. Safety of 6-week Neonatal Triple-combination Antiretroviral Postexposure Prophylaxis in High-risk HIV-exposed Infants.
Anugulruengkitt S; Suntarattiwong P; Ounchanum P; Srirompotong U; Jantarabenjakul W; Sophonphan J; Punnahitanon S; Pancharoen C; Cressey TR; Chokephaibulkit K; Puthanakit T;
Pediatr Infect Dis J; 2019 Oct; 38(10):1045-1050. PubMed ID: 31365477
[TBL] [Abstract][Full Text] [Related]
2. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
Volmink J; Siegfried NL; van der Merwe L; Brocklehurst P
Cochrane Database Syst Rev; 2007 Jan; (1):CD003510. PubMed ID: 17253490
[TBL] [Abstract][Full Text] [Related]
3. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
Siegfried N; van der Merwe L; Brocklehurst P; Sint TT
Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394
[TBL] [Abstract][Full Text] [Related]
4. Serious adverse events are uncommon with combination neonatal antiretroviral prophylaxis: a retrospective case review.
Smith C; Forster JE; Levin MJ; Davies J; Pappas J; Kinzie K; Barr E; Paul S; McFarland EJ; Weinberg A
PLoS One; 2015; 10(5):e0127062. PubMed ID: 26000984
[TBL] [Abstract][Full Text] [Related]
5. Nevirapine Concentrations During the First Month of Life and Maternal Efavirenz Washout in High-Risk HIV-Exposed Infants Receiving Triple Antiretroviral Prophylaxis.
Anugulruengkitt S; Cressey TR; Suntarattiwong P; Ounchanum P; Srirompotong U; Jantarabenjakul W; Sophonphan J; Tawon Y; Punnahitanon S; Pancharoen C; Chokephaibulkit K; Puthanakit T;
Pediatr Infect Dis J; 2019 Feb; 38(2):152-156. PubMed ID: 30204660
[TBL] [Abstract][Full Text] [Related]
6. Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.
Coffie PA; Ekouevi DK; Chaix ML; Tonwe-Gold B; Clarisse AB; Becquet R; Viho I; N'dri-Yoman T; Leroy V; Abrams EJ; Rouzioux C; Dabis F
Clin Infect Dis; 2008 Feb; 46(4):611-21. PubMed ID: 18197758
[TBL] [Abstract][Full Text] [Related]
7. Choice of antiretroviral drugs for postexposure prophylaxis for children: a systematic review.
Penazzato M; Dominguez K; Cotton M; Barlow-Mosha L; Ford N
Clin Infect Dis; 2015 Jun; 60 Suppl 3():S177-81. PubMed ID: 25972500
[TBL] [Abstract][Full Text] [Related]
8. A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1.
Moodley D; Moodley J; Coovadia H; Gray G; McIntyre J; Hofmyer J; Nikodem C; Hall D; Gigliotti M; Robinson P; Boshoff L; Sullivan JL;
J Infect Dis; 2003 Mar; 187(5):725-35. PubMed ID: 12599045
[TBL] [Abstract][Full Text] [Related]
9. Nevirapine and zidovudine at birth to reduce perinatal transmission of HIV in an African setting: a randomized controlled trial.
Taha TE; Kumwenda NI; Hoover DR; Fiscus SA; Kafulafula G; Nkhoma C; Nour S; Chen S; Liomba G; Miotti PG; Broadhead RL
JAMA; 2004 Jul; 292(2):202-9. PubMed ID: 15249569
[TBL] [Abstract][Full Text] [Related]
10. Comparative Safety of Antiretroviral Treatment Regimens in Pregnancy.
Zash R; Jacobson DL; Diseko M; Mayondi G; Mmalane M; Essex M; Petlo C; Lockman S; Makhema J; Shapiro RL
JAMA Pediatr; 2017 Oct; 171(10):e172222. PubMed ID: 28783807
[TBL] [Abstract][Full Text] [Related]
11. Is there a difference in the efficacy of peripartum antiretroviral regimens in reducing mother-to-child transmission of HIV in Africa?
Leroy V; Sakarovitch C; Cortina-Borja M; McIntyre J; Coovadia H; Dabis F; Newell ML; Saba J; Gray G; Ndugwa Ch; Kilewo Ch; Massawe A; Kituuka P; Okong P; Grulich A; von Briesen H; Goudsmit J; Biberfeld G; Haverkamp G; Weverling GJ; Lange JM;
AIDS; 2005 Nov; 19(16):1865-75. PubMed ID: 16227795
[TBL] [Abstract][Full Text] [Related]
12. Randomized noninferiority trial of two maternal single-dose nevirapine-sparing regimens to prevent perinatal HIV in Thailand.
Lallemant M; Le Coeur S; Sirirungsi W; Cressey TR; Ngo-Giang-Huong N; Traisathit P; Klinbuayaem V; Sabsanong P; Kanjanavikai P; Jourdain G; Mcintosh K; Koetsawang S;
AIDS; 2015 Nov; 29(18):2497-507. PubMed ID: 26372485
[TBL] [Abstract][Full Text] [Related]
13. Postexposure prophylaxis of breastfeeding HIV-exposed infants with antiretroviral drugs to age 14 weeks: updated efficacy results of the PEPI-Malawi trial.
Taha TE; Li Q; Hoover DR; Mipando L; Nkanaunena K; Thigpen MC; Taylor A; Kumwenda J; Fowler MG; Mofenson LM; Kumwenda NI
J Acquir Immune Defic Syndr; 2011 Aug; 57(4):319-25. PubMed ID: 21423025
[TBL] [Abstract][Full Text] [Related]
14. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
Sturt AS; Dokubo EK; Sint TT
Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
[TBL] [Abstract][Full Text] [Related]
15. 18-month effectiveness of short-course antiretroviral regimens combined with alternatives to breastfeeding to prevent HIV mother-to-child transmission.
Leroy V; Ekouevi DK; Becquet R; Viho I; Dequae-Merchadou L; Tonwe-Gold B; Rouet F; Sakarovitch C; Horo A; Timité-Konan M; Rouzioux C; Dabis F;
PLoS One; 2008 Feb; 3(2):e1645. PubMed ID: 18286200
[TBL] [Abstract][Full Text] [Related]
16. Addition of extended zidovudine to extended nevirapine prophylaxis reduces nevirapine resistance in infants who were HIV-infected in utero.
Lidström J; Li Q; Hoover DR; Kafulafula G; Mofenson LM; Fowler MG; Thigpen MC; Kumwenda N; Taha TE; Eshleman SH
AIDS; 2010 Jan; 24(3):381-6. PubMed ID: 19996936
[TBL] [Abstract][Full Text] [Related]
17. Analysis of nevirapine resistance in HIV-infected infants who received extended nevirapine or nevirapine/zidovudine prophylaxis.
Fogel J; Hoover DR; Sun J; Mofenson LM; Fowler MG; Taylor AW; Kumwenda N; Taha TE; Eshleman SH
AIDS; 2011 Apr; 25(7):911-7. PubMed ID: 21487249
[TBL] [Abstract][Full Text] [Related]
18. Highly active antiretroviral therapy versus zidovudine/nevirapine effects on early breast milk HIV type-1 Rna: a phase II randomized clinical trial.
Chung MH; Kiarie JN; Richardson BA; Lehman DA; Overbaugh J; Kinuthia J; Njiri F; John-Stewart GC
Antivir Ther; 2008; 13(6):799-807. PubMed ID: 18839781
[TBL] [Abstract][Full Text] [Related]
19. Assessment of adverse events associated with antiretroviral regimens for postexposure prophylaxis for occupational and nonoccupational exposures to prevent transmission of human immunodeficiency virus.
Luque A; Hulse S; Wang D; Shahzad U; Tanzman E; Antenozzi S; Smith B
Infect Control Hosp Epidemiol; 2007 Jun; 28(6):695-701. PubMed ID: 17520543
[TBL] [Abstract][Full Text] [Related]
20. Three postpartum antiretroviral regimens to prevent intrapartum HIV infection.
Nielsen-Saines K; Watts DH; Veloso VG; Bryson YJ; Joao EC; Pilotto JH; Gray G; Theron G; Santos B; Fonseca R; Kreitchmann R; Pinto J; Mussi-Pinhata MM; Ceriotto M; Machado D; Bethel J; Morgado MG; Dickover R; Camarca M; Mirochnick M; Siberry G; Grinsztejn B; Moreira RI; Bastos FI; Xu J; Moye J; Mofenson LM;
N Engl J Med; 2012 Jun; 366(25):2368-79. PubMed ID: 22716975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
